The role of ranolazine in managing chronic coronary syndrome: a synthesis of clinical outcomes and health economic modelling
Patients with chronic coronary syndrome (CCS) frequently experience ongoing angina, diminished quality of life (QoL), and face a heightened need for revascularisation procedures. The present analysis aimed to consolidate clinical and health economic data regarding the use of ranolazine in CCS. By combining...